We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharma Exclusivity Could Be Sticking Point on Trans-Pacific Partnership Pact
Pharma Exclusivity Could Be Sticking Point on Trans-Pacific Partnership Pact
Pharmaceutical intellectual property rights remain a significant sticking point in a proposed draft of the massive Trans-Pacific Partnership trade pact leaked in October.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor